These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 30207286

  • 1. Prognostic value of total lesion glycolysis and metabolic active tumor volume in non-small cell lung cancer.
    Vanhove K, Mesotten L, Heylen M, Derwael R, Louis E, Adriaensens P, Thomeer M, Boellaard R.
    Cancer Treat Res Commun; 2018; 15():7-12. PubMed ID: 30207286
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y.
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [Abstract] [Full Text] [Related]

  • 3. Prognostic significance of total lesion glycolysis in patients with advanced non-small cell lung cancer receiving chemotherapy.
    Zaizen Y, Azuma K, Kurata S, Sadashima E, Hattori S, Sasada T, Imamura Y, Kaida H, Kawahara A, Kinoshita T, Ishibashi M, Hoshino T.
    Eur J Radiol; 2012 Dec; 81(12):4179-84. PubMed ID: 22884163
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.
    Chen HH, Chiu NT, Su WC, Guo HR, Lee BF.
    Radiology; 2012 Aug; 264(2):559-66. PubMed ID: 22692034
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of total lesion glycolysis by 18F-FDG PET/CT in surgically resected stage IA non-small cell lung cancer.
    Park SY, Cho A, Yu WS, Lee CY, Lee JG, Kim DJ, Chung KY.
    J Nucl Med; 2015 Jan; 56(1):45-9. PubMed ID: 25525185
    [Abstract] [Full Text] [Related]

  • 6. Total lesion glycolysis by 18F-FDG PET/CT is independent prognostic factor in patients with advanced non-small cell lung cancer.
    Yıldırım F, Yurdakul AS, Özkaya S, Akdemir ÜÖ, Öztürk C.
    Clin Respir J; 2017 Sep; 11(5):602-611. PubMed ID: 26434685
    [Abstract] [Full Text] [Related]

  • 7. Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents.
    Hwang SH, Cho A, Yun M, Choi YD, Rha SY, Kang WJ.
    Clin Nucl Med; 2017 May; 42(5):e235-e241. PubMed ID: 28288043
    [Abstract] [Full Text] [Related]

  • 8. Predictive and Prognostic Role of Metabolic Response in Patients With Stage III NSCLC Treated With Neoadjuvant Chemotherapy.
    Castello A, Toschi L, Rossi S, Finocchiaro G, Grizzi F, Mazziotti E, Qehajaj D, Rahal D, Lopci E.
    Clin Lung Cancer; 2020 Jan; 21(1):28-36. PubMed ID: 31409523
    [Abstract] [Full Text] [Related]

  • 9. Role of Various Metabolic Parameters Derived From Baseline 18F-FDG PET/CT as Prognostic Markers in Non-Small Cell Lung Cancer Patients Undergoing Platinum-Based Chemotherapy.
    Sharma A, Mohan A, Bhalla AS, Sharma MC, Vishnubhatla S, Das CJ, Pandey AK, Sekhar Bal C, Patel CD, Sharma P, Agarwal KK, Kumar R.
    Clin Nucl Med; 2018 Jan; 43(1):e8-e17. PubMed ID: 29112011
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer.
    Liao S, Penney BC, Zhang H, Suzuki K, Pu Y.
    Acad Radiol; 2012 Jan; 19(1):69-77. PubMed ID: 22142679
    [Abstract] [Full Text] [Related]

  • 11. Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection.
    Hyun SH, Choi JY, Kim K, Kim J, Shim YM, Um SW, Kim H, Lee KH, Kim BT.
    Ann Surg; 2013 Feb; 257(2):364-70. PubMed ID: 22968069
    [Abstract] [Full Text] [Related]

  • 12. Volumetric PET parameters can predict overall survival in advanced lung adenocarcinoma.
    Yanarateş A, Yazici B.
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020 Feb; 39(1):3-8. PubMed ID: 31818695
    [Abstract] [Full Text] [Related]

  • 13. Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma.
    Satoh K, Patel D, Dieckmann W, Nilubol N, Kebebew E.
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S714-20. PubMed ID: 26282908
    [Abstract] [Full Text] [Related]

  • 14. Validation of Metabolically Active Tumor Volume and Total Lesion Glycolysis as 18F-FDG PET/CT–derived Prognostic Biomarkers in Chemorefractory Metastatic Colorectal Cancer.
    Woff E, Hendlisz A, Ameye L, Garcia C, Kamoun T, Guiot T, Paesmans M, Flamen P.
    J Nucl Med; 2019 Feb 01; 60(2):178-184. PubMed ID: 29959212
    [Abstract] [Full Text] [Related]

  • 15. Tumor lesion glycolysis and tumor lesion proliferation for response prediction and prognostic differentiation in patients with advanced non-small cell lung cancer treated with erlotinib.
    Kahraman D, Holstein A, Scheffler M, Zander T, Nogova L, Lammertsma AA, Boellaard R, Neumaier B, Dietlein M, Wolf J, Kobe C.
    Clin Nucl Med; 2012 Nov 01; 37(11):1058-64. PubMed ID: 23027207
    [Abstract] [Full Text] [Related]

  • 16. Prognostic Significance of Standardized Uptake Value of Lymph Nodes on Survival for Stage III Non-small Cell Lung Cancer Treated With Definitive Concurrent Chemoradiotherapy.
    Lee VH, Chan WW, Lee EY, Choy TS, Ho PP, Leung DK, Lam KO, Kwong DL, Leung TW, Khong PL.
    Am J Clin Oncol; 2016 Aug 01; 39(4):355-62. PubMed ID: 24710123
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer.
    Vu CC, Matthews R, Kim B, Franceschi D, Bilfinger TV, Moore WH.
    Nucl Med Commun; 2013 Oct 01; 34(10):959-63. PubMed ID: 23921784
    [Abstract] [Full Text] [Related]

  • 18. Primary tumor standardized uptake value (SUVmax) measured on 18F-FDG PET/CT and mixed NSCLC components predict survival in surgical-resected combined small-cell lung cancer.
    Hui Z, Wei F, Ren H, Xu W, Ren X.
    J Cancer Res Clin Oncol; 2020 Oct 01; 146(10):2595-2605. PubMed ID: 32494919
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of volumetric parameters measured by F-18 FDG PET/CT in surgically resected non-small-cell lung cancer.
    Kim K, Kim SJ, Kim IJ, Kim YS, Pak K, Kim H.
    Nucl Med Commun; 2012 Jun 01; 33(6):613-20. PubMed ID: 22407127
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of metabolic parameters measured by 18F-FDG PET/CT in limited-stage small-cell lung carcinoma.
    Chang H, Lee SJ, Lim J, Lee JS, Kim YJ, Lee WW.
    J Cancer Res Clin Oncol; 2019 May 01; 145(5):1361-1367. PubMed ID: 30900157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.